Human Hepatocellular response in Cholestatic Liver Diseases

Organogenesis. 2023 Dec 31;19(1):2247576. doi: 10.1080/15476278.2023.2247576.

Abstract

Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), the most common types of cholestatic liver disease (CLD), result in enterohepatic obstruction, bile acid accumulation, and hepatotoxicity. The mechanisms by which hepatocytes respond to and cope with CLD remain largely unexplored. This study includes the characterization of hepatocytes isolated from explanted livers of patients with PBC and PSC. We examined the expression of hepatocyte-specific genes, intracellular bile acid (BA) levels, and oxidative stress in primary-human-hepatocytes (PHHs) isolated from explanted livers of patients with PBC and PSC and compared them with control normal human hepatocytes. Our findings provide valuable initial insights into the hepatocellular response to cholestasis in CLD and help support the use of PHHs as an experimental tool for these diseases.

Keywords: Cholestasis; hepatocellular response; human hepatocytes; primary biliary cholangitis; primary sclerosing cholangitis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Bile Acids and Salts
  • Carcinoma, Hepatocellular*
  • Cholestasis*
  • Humans
  • Liver Neoplasms*

Substances

  • Bile Acids and Salts